Skip to main content

Table 3 Characteristics of the 12 intermediate-risk EEC patients with nodal metastasis

From: Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

No. Age range (years) Tumor grade Myometrial invasion LVSI Tumor maximun diameter(mm) Lesion location Para-aortic LND Location of involved lymph node Observation time(months) Adjuvant treatmentb Outcome
1 60–65 G1 <50% no 80 diffuse lesion no right obturator 1/7 94 refused NED
2 55–60 G1 <50% no 62 diffuse lesion no left iliac vessel 1/5 42 refused NED
3 50–55 G2 <50% no 24 Side wall no right obturator 1/2 124 chemotherapy + radiotherapy NED
4 60–65 G2 <50% no 45 diffuse lesion no right obturator 1/3 61 radiotherapy NED
5a 55–60 G2 <50% no 30 fundus yes left obturator 1/4 35 chemotherapy NED
6 60–65 G1 <50% yes 50 diffuse lesion no right iliac vessel 1/6 36 chemotherapy NED
7 40–45 G1 <50% no 20 right cornua no right obturator 1/1 38 refused NED
8a 60–65 G2 <50% yes 35 left cornua yes solely para-aortic 1/6 28 refused NED
9a 50–55 G1 <50% no 22 right cornua no left iliac vessel 1/5 12 radiotherapy NED
10a 45–50 G1 <50% no 60 diffuse lesion yes left iliac vessel 2/8 24 refused NED
11a 50–55 G1 <50% with MELF yes 40 fundus no left iliac vessel 1/9 12 refused NED
12a 45–50 G1 <50% with MELF yes 75 diffuse lesion yes left iliac vessel 1/10,right iliac vessel 1/10, para-aortic 1/7 12 chemotherapy + radiotherapy NED
  1. LND lymph node dissection
  2. NED no evidence of disease
  3. aThe surgery dates of these 12 patients range from October 1999 to December 2015, thus 6 patients were observed less than 36 months postoperatively
  4. bPatients who received chemotherapy were all treated with paclitaxel and carboplatin for 6 cycles. Patients underwent radiotherapy were given external- beam radiation therapy (EBRT) as 5040 cGy given as 28 fractions of 180 cGy